Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SIM0713
- Development stage
- Unknown
- Lead developer
- Simcere Pharmaceutical Group
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
SIM0713 is a potent and highly selective small molecule inhibitor of Janus kinase 1 (JAK1), currently under development by Simcere Pharmaceutical for the treatment of autoimmune and inflammatory disorders. By targeting the JAK1 isoform, SIM0713 selectively blocks the signaling of key pro-inflammatory cytokines, including interleukin-6 (IL-6) and interferons, which play central roles in the pathogenesis of diseases such as atopic dermatitis and rheumatoid arthritis. This selectivity is designed to provide therapeutic efficacy while minimizing off-target effects associated with the inhibition of other JAK family members, such as JAK2 (linked to erythropoiesis) and JAK3 (linked to lymphocyte function). SIM0713 is administered orally and has progressed into Phase 2 clinical trials for moderate-to-severe atopic dermatitis.
- Other names
- JAH
02
Targets
Beyond the preview
Go deeper on SIM0713.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SIM0713.